vs
Side-by-side financial comparison of CMB.TECH NV (CMBT) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $592.8M, roughly 1.0× CMB.TECH NV). CMB.TECH NV runs the higher net margin — 32.3% vs 3.3%, a 28.9% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs -34.6%).
CMB.TECH, before October 2024 known as Euronav, is a crude oil tanker transport company, which consists of VLCCs, Suezmaxes and FSOs.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
CMBT vs HIMS — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $592.8M | $617.8M |
| Net Profit | $191.2M | $20.6M |
| Gross Margin | — | 71.9% |
| Operating Margin | 46.4% | 1.5% |
| Net Margin | 32.3% | 3.3% |
| Revenue YoY | -34.6% | 28.4% |
| Net Profit YoY | -63.3% | -20.8% |
| EPS (diluted) | $1.01 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $617.8M | ||
| Q3 25 | — | $599.0M | ||
| Q2 25 | — | $544.8M | ||
| Q1 25 | — | $586.0M | ||
| Q4 24 | $592.8M | $481.1M | ||
| Q3 24 | — | $401.6M | ||
| Q2 24 | — | $315.6M | ||
| Q1 24 | — | $278.2M |
| Q4 25 | — | $20.6M | ||
| Q3 25 | — | $15.8M | ||
| Q2 25 | — | $42.5M | ||
| Q1 25 | — | $49.5M | ||
| Q4 24 | $191.2M | $26.0M | ||
| Q3 24 | — | $75.6M | ||
| Q2 24 | — | $13.3M | ||
| Q1 24 | — | $11.1M |
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 73.8% | ||
| Q2 25 | — | 76.4% | ||
| Q1 25 | — | 73.5% | ||
| Q4 24 | — | 76.8% | ||
| Q3 24 | — | 79.2% | ||
| Q2 24 | — | 81.3% | ||
| Q1 24 | — | 82.4% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 4.9% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | 46.4% | 3.9% | ||
| Q3 24 | — | 5.6% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 3.6% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 7.8% | ||
| Q1 25 | — | 8.4% | ||
| Q4 24 | 32.3% | 5.4% | ||
| Q3 24 | — | 18.8% | ||
| Q2 24 | — | 4.2% | ||
| Q1 24 | — | 4.0% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | — | $0.17 | ||
| Q1 25 | — | $0.20 | ||
| Q4 24 | $1.01 | $0.10 | ||
| Q3 24 | — | $0.32 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $38.9M | $228.6M |
| Total DebtLower is stronger | $2.6B | — |
| Stockholders' EquityBook value | $1.2B | $540.9M |
| Total Assets | $3.9B | $2.2B |
| Debt / EquityLower = less leverage | 2.20× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $228.6M | ||
| Q3 25 | — | $345.8M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $273.7M | ||
| Q4 24 | $38.9M | $220.6M | ||
| Q3 24 | — | $165.5M | ||
| Q2 24 | — | $129.3M | ||
| Q1 24 | — | $105.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $540.9M | ||
| Q3 25 | — | $581.0M | ||
| Q2 25 | — | $562.7M | ||
| Q1 25 | — | $549.3M | ||
| Q4 24 | $1.2B | $476.7M | ||
| Q3 24 | — | $440.1M | ||
| Q2 24 | — | $362.0M | ||
| Q1 24 | — | $344.5M |
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $891.7M | ||
| Q4 24 | $3.9B | $707.5M | ||
| Q3 24 | — | $602.3M | ||
| Q2 24 | — | $480.5M | ||
| Q1 24 | — | $448.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $204.4M | $61.3M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -0.4% |
| Capex IntensityCapex / Revenue | — | 10.3% |
| Cash ConversionOCF / Net Profit | 1.07× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | — | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $61.3M | ||
| Q3 25 | — | $148.7M | ||
| Q2 25 | — | $-19.1M | ||
| Q1 25 | — | $109.1M | ||
| Q4 24 | $204.4M | $86.4M | ||
| Q3 24 | — | $85.3M | ||
| Q2 24 | — | $53.6M | ||
| Q1 24 | — | $25.8M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $79.3M | ||
| Q2 25 | — | $-69.5M | ||
| Q1 25 | — | $50.1M | ||
| Q4 24 | — | $59.5M | ||
| Q3 24 | — | $79.4M | ||
| Q2 24 | — | $47.6M | ||
| Q1 24 | — | $11.8M |
| Q4 25 | — | -0.4% | ||
| Q3 25 | — | 13.2% | ||
| Q2 25 | — | -12.8% | ||
| Q1 25 | — | 8.5% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 19.8% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | — | 4.3% |
| Q4 25 | — | 10.3% | ||
| Q3 25 | — | 11.6% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | 10.1% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 5.0% |
| Q4 25 | — | 2.98× | ||
| Q3 25 | — | 9.43× | ||
| Q2 25 | — | -0.45× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | 1.07× | 3.32× | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 4.03× | ||
| Q1 24 | — | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
